Deadly "superbugs," or microbes that can resist antibiotics, are on the rise and killing hundreds of thousands of people annually. Pharmaceutical companies, however, are typically slow to invest in the search for new drugs for financial reasons. That's according to infectious-disease doctor Matt McCarthy, who chronicles this conflict in his new book, "Superbugs: The Race to Stop an Epidemic." We'll talk with Dr. McCarthy about the future of these "superbugs" and his clinical trial testing a new antibiotic to fight them.
Responding to the Rise of Antibiotic-Resistant 'Superbugs'
This article is more than 3 years old.
Dr. Matt McCarthy, staff physician, New York Presbyterian Hospital; bestselling author of "The Real Doctor Will See You Now" and "Odd Man Out"